Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Sunderland

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Treatment and Research|January 1, 1991
Oncogenes as clinical prognostic indicatorsM C Sunderland, W L McGuire
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Interleukin-3. Its biology and potential uses in pediatric hematology/oncologyM C Sunderland, G D Roodman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Tamoxifen in premenopausal patients with metastatic breast cancer: a reviewM C Sunderland, C K Osborne
The Surgical Clinics of North America|October 1, 1990
Prognostic indicators in invasive breast cancerM C Sunderland, W L McGuire
Trends in Endocrinology and Metabolism: TEM|March 1, 1991
Hormones and breast cancerM C Sunderland, W L McGuire
Digestive Diseases and Sciences|October 1, 1986
Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapyE B Keeffe, M C Sunderland, J D Gabourel
Dermatology (Basel, Switzerland)|January 1, 1996
Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human interleukin 4G R Weiss, S H Fehrenkamp, L K Tokaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancerC K Osborne, M C Sunderland, J A Neidhart, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Treatment and Research|January 1, 1991
Oncogenes as clinical prognostic indicatorsM C Sunderland, W L McGuire
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Interleukin-3. Its biology and potential uses in pediatric hematology/oncologyM C Sunderland, G D Roodman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Tamoxifen in premenopausal patients with metastatic breast cancer: a reviewM C Sunderland, C K Osborne
The Surgical Clinics of North America|October 1, 1990
Prognostic indicators in invasive breast cancerM C Sunderland, W L McGuire
Trends in Endocrinology and Metabolism: TEM|March 1, 1991
Hormones and breast cancerM C Sunderland, W L McGuire
Digestive Diseases and Sciences|October 1, 1986
Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapyE B Keeffe, M C Sunderland, J D Gabourel
Dermatology (Basel, Switzerland)|January 1, 1996
Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human interleukin 4G R Weiss, S H Fehrenkamp, L K Tokaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancerC K Osborne, M C Sunderland, J A Neidhart, et al.
Pageof 1